Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
Phase 1
Completed
- Conditions
- Opiate DependenceChronic Pain
- Interventions
- Behavioral: Cognitive-Behavioral Therapy for Pain and Opioid DependenceBehavioral: Methadone Drug Counseling
- Registration Number
- NCT01334580
- Lead Sponsor
- Yale University
- Brief Summary
This study involves the comparison of two treatment approaches for patients with chronic pain who are entering methadone maintenance treatment (MMT) for opioid addiction: (a) an integrated counseling that addresses both chronic pain and opioid dependence(POD)and (b) a counseling intervention that addresses opioid dependence only.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- 18 years of age or older
- prescription opioid or heroin addiction
- moderate to severe chronic pain
- enrolled in methadone maintenance at the APT Foundation for opioid addiction
- understand English
Read More
Exclusion Criteria
- current suicide or homicide risk
- life-threatening or unstable medical problem
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Cognitive-Behavioral Therapy for Pain and Opioid Dependence Cognitive-Behavioral Therapy for Pain and Opioid Dependence CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management. Methadone Drug Counseling Methadone Drug Counseling Methadone Drug Counseling is provided by skilled drug counselors over a 12 week period and focuses on cessation of illicit drugs
- Primary Outcome Measures
Name Time Method Pain reduction 16 weeks Reduce illicit opioid use 16 weeks
- Secondary Outcome Measures
Name Time Method Finalization of treatment manuals 16 weeks Development and modification of therapy training and process rating measures 16 weeks
Trial Locations
- Locations (1)
Methadone Research Unit
🇺🇸New Haven, Connecticut, United States